SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-22-295581
Filing Date
2022-12-01
Accepted
2022-11-30 18:49:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A d287522ds3a.htm S-3/A 230443
2 EX-23.1 d287522dex231.htm EX-23.1 2098
3 EX-23.2 d287522dex232.htm EX-23.2 1879
4 GRAPHIC g287522g02m23.jpg GRAPHIC 90211
  Complete submission text file 0001193125-22-295581.txt   359876
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-267888 | Film No.: 221436701
SIC: 2834 Pharmaceutical Preparations